THE NEXT-GENERATION
BRAIN MONITORING COMPANY

The right AI tools for brain monitoring in intensive care.
Learn more

Now available
in Europe

C-Trend® technology is now approved
as a CLASS IIb medical device in the EU.
Learn more

Our story so far

Find out how the story of Cerenion began as a spin-off from the University of Oulu in Finland, and where we are going today.
Learn more

INTRODUCING
THE "PULSE" OF THE BRAIN™

In intensive care, the heart and the lungs are closely monitored, but the brain is not routinely monitored. Brain monitoring is often seen as too difficult and time-consuming, yet it is perhaps the most vital of human organs.
Our scientifically-proven Cerenion C-Trend® changes this.
Cerenion C-Trend® -powered EEG devices provide a new level of ease and confidence in monitoring the neurophysiological status of patients. Based on Artificial Intelligence (AI), the C-Trend® software processes the complex EEG recording to produce a set of easy parameters to aid medical professionals in clinical decision making.
The indications for use of C-Trend® include monitoring of brain function in comatose cardiac arrest survivors as well as detecting epileptic seizure activity and brain hypoxia.

CERENION C-TREND® reveals the status of the brain

– at the bed-side and without requiring any changes to the care of the patient.

Latest news

18.03.2024

Cerenion C-Trend® Software Library receives MDR Certificate

Read more

RESULTS WITHIN MINUTES

CERENION C-TREND® provides a fast, reliable and inexpensive view into the brain – all without requiring any changes to the care of the patient. See how the patien't brain is doing just like taking their pulse.
Learn more about C-Trend®

Excellence you can trust.
Science you can rely on.

Our technology is founded on over a decade of research at the University of Oulu, Finland, and meticulously evaluated in collaboration with our partners. Our own clinical multisite study program provides strong evidence on the clinical indications we give for the technology.
The Cerenion C-Trend® is a CE-marked Class IIb medical device that has passed EC conformity assessment by a notified body in order to be released under the Medical Device Directive of the European Union (EU MDD 93/42/EEC).

Class IIb medical device under EU MDD

EC conformity assessment by a notified body (SGS Fimko)

Certified Quality Management

ISO 13485:2016 certification by a notified body (SGS Fimko)

IEC 62304 -conformant software

External IEC 62304 conformance assessment (SGS Fimko)

Now available in Europe

C-Trend® technology is now approved as a CLASS IIb medical device in Europe.
Click here to find out more
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
OULU
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
FINLAND
HELSINKI
Cerenion Oy
Kyllikinportti 2
00240 Helsinki
FINLAND
Call us: +358 50 447 4909
E-mail us:
Follow us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2024 Cerenion Oy